These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 19289055)

  • 1. Agitation and high ionic strength induce amyloidogenesis of a folded PDZ domain in native conditions.
    Sicorello A; Torrassa S; Soldi G; Gianni S; Travaglini-Allocatelli C; Taddei N; Relini A; Chiti F
    Biophys J; 2009 Mar; 96(6):2289-98. PubMed ID: 19289055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Existence of different structural intermediates on the fibrillation pathway of human serum albumin.
    Juárez J; Taboada P; Mosquera V
    Biophys J; 2009 Mar; 96(6):2353-70. PubMed ID: 19289061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid fibril formation by a normally folded protein in the absence of denaturants and agitation.
    Shokri MM; Ahmadian S; Bemporad F; Khajeh K; Chiti F
    Amyloid; 2013 Dec; 20(4):226-32. PubMed ID: 24053331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partially folded intermediates as critical precursors of light chain amyloid fibrils and amorphous aggregates.
    Khurana R; Gillespie JR; Talapatra A; Minert LJ; Ionescu-Zanetti C; Millett I; Fink AL
    Biochemistry; 2001 Mar; 40(12):3525-35. PubMed ID: 11297418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salt-induced modulation of the pathway of amyloid fibril formation by the mouse prion protein.
    Jain S; Udgaonkar JB
    Biochemistry; 2010 Sep; 49(35):7615-24. PubMed ID: 20712298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid-like fibril formation in an all beta-barrel protein. Partially structured intermediate state(s) is a precursor for fibril formation.
    Srisailam S; Kumar TK; Rajalingam D; Kathir KM; Sheu HS; Jan FJ; Chao PC; Yu C
    J Biol Chem; 2003 May; 278(20):17701-9. PubMed ID: 12584201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinguishing crystal-like amyloid fibrils and glass-like amorphous aggregates from their kinetics of formation.
    Yoshimura Y; Lin Y; Yagi H; Lee YH; Kitayama H; Sakurai K; So M; Ogi H; Naiki H; Goto Y
    Proc Natl Acad Sci U S A; 2012 Sep; 109(36):14446-51. PubMed ID: 22908252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic analysis of amyloid formation in the presence of heparan sulfate: faster unfolding and change of pathway.
    Motamedi-Shad N; Monsellier E; Torrassa S; Relini A; Chiti F
    J Biol Chem; 2009 Oct; 284(43):29921-34. PubMed ID: 19700762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partially unfolded states of beta(2)-microglobulin and amyloid formation in vitro.
    McParland VJ; Kad NM; Kalverda AP; Brown A; Kirwin-Jones P; Hunter MG; Sunde M; Radford SE
    Biochemistry; 2000 Aug; 39(30):8735-46. PubMed ID: 10913285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural studies reveal that the diverse morphology of beta(2)-microglobulin aggregates is a reflection of different molecular architectures.
    Kardos J; Okuno D; Kawai T; Hagihara Y; Yumoto N; Kitagawa T; Závodszky P; Naiki H; Goto Y
    Biochim Biophys Acta; 2005 Nov; 1753(1):108-20. PubMed ID: 16185940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrasonication-induced amyloid fibril formation of beta2-microglobulin.
    Ohhashi Y; Kihara M; Naiki H; Goto Y
    J Biol Chem; 2005 Sep; 280(38):32843-8. PubMed ID: 16046408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversible amyloid formation by the p53 tetramerization domain and a cancer-associated mutant.
    Lee AS; Galea C; DiGiammarino EL; Jun B; Murti G; Ribeiro RC; Zambetti G; Schultz CP; Kriwacki RW
    J Mol Biol; 2003 Mar; 327(3):699-709. PubMed ID: 12634062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for a mechanism of amyloid formation involving molecular reorganisation within native-like precursor aggregates.
    Plakoutsi G; Bemporad F; Calamai M; Taddei N; Dobson CM; Chiti F
    J Mol Biol; 2005 Aug; 351(4):910-22. PubMed ID: 16024042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid fibril formation by a partially structured intermediate state of alpha-chymotrypsin.
    Pallarès I; Vendrell J; Avilés FX; Ventura S
    J Mol Biol; 2004 Sep; 342(1):321-31. PubMed ID: 15313627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformational prerequisites for formation of amyloid fibrils from histones.
    Munishkina LA; Fink AL; Uversky VN
    J Mol Biol; 2004 Sep; 342(4):1305-24. PubMed ID: 15351653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Searching for conditions to form stable protein oligomers with amyloid-like characteristics: The unexplored basic pH.
    Ahmad B; Winkelmann J; Tiribilli B; Chiti F
    Biochim Biophys Acta; 2010 Jan; 1804(1):223-34. PubMed ID: 19836473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into Kinetics of Agitation-Induced Aggregation of Hen Lysozyme under Heat and Acidic Conditions from Various Spectroscopic Methods.
    Chaari A; Fahy C; Chevillot-Biraud A; Rholam M
    PLoS One; 2015; 10(11):e0142095. PubMed ID: 26571264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation as conformational switch from the native to amyloid state: Trp-cage as a protein aggregation model.
    Kardos J; Kiss B; Micsonai A; Rovó P; Menyhárd DK; Kovács J; Váradi G; Tóth GK; Perczel A
    J Phys Chem B; 2015 Feb; 119(7):2946-55. PubMed ID: 25625571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid-beta protofibrils differ from amyloid-beta aggregates induced in dilute hexafluoroisopropanol in stability and morphology.
    Nichols MR; Moss MA; Reed DK; Cratic-McDaniel S; Hoh JH; Rosenberry TL
    J Biol Chem; 2005 Jan; 280(4):2471-80. PubMed ID: 15528204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin induces harmless fibril formation in amyloidogenic W7FW14F apomyoglobin and amyloid aggregation in wild-type protein in vitro.
    Vilasi S; Sarcina R; Maritato R; De Simone A; Irace G; Sirangelo I
    PLoS One; 2011; 6(7):e22076. PubMed ID: 21779376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.